Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Buildit's Profile
Displaying 101-150 of 2000 result(s).
GNBTQ Generex Biotechnology Corp.
07/19/2021 9:23:07 PM
RJS, it seems maybe you are answeri
GNBTQ Generex Biotechnology Corp.
07/19/2021 8:23:42 PM
I believe it was based on approval,
GNBTQ Generex Biotechnology Corp.
07/19/2021 10:52:32 AM
Hey, RV, From the 5/6 call (Rich): (6)
GNBTQ Generex Biotechnology Corp.
07/19/2021 10:04:15 AM
Understood, Beasley (and Joe), Howe (3)
GNBTQ Generex Biotechnology Corp.
07/19/2021 9:38:03 AM
Agreed, Doc. As we approach the end (10)
GNBTQ Generex Biotechnology Corp.
07/17/2021 7:59:48 PM
Well, Drexel, once people know your (7)
GNBTQ Generex Biotechnology Corp.
07/16/2021 4:35:52 PM
“Congratulations”, RV, and welc (3)
GNBTQ Generex Biotechnology Corp.
07/13/2021 2:32:52 PM
I think the low volume indicates th (6)
GNBTQ Generex Biotechnology Corp.
07/12/2021 9:11:48 AM
There is little doubt in my mind th (5)
GNBTQ Generex Biotechnology Corp.
07/09/2021 9:17:36 AM
Yes, I am assuming everything excep (2)
GNBTQ Generex Biotechnology Corp.
07/09/2021 8:58:52 AM
Well, May 18th was supposed to be t (10)
GNBTQ Generex Biotechnology Corp.
06/30/2021 8:41:52 PM
Yeah, they are issuing 65% more sha
GNBTQ Generex Biotechnology Corp.
06/29/2021 8:41:26 AM
Even IF the virus does not mutate b (1)
GNBTQ Generex Biotechnology Corp.
06/27/2021 7:02:35 PM
Despite public statements to the co
GNBTQ Generex Biotechnology Corp.
06/25/2021 1:39:11 PM
My understanding was that the IND w (1)
GNBTQ Generex Biotechnology Corp.
06/24/2021 1:16:22 PM
https://www.sec.gov/ix?doc=/Archiv
GNBTQ Generex Biotechnology Corp.
06/22/2021 5:15:29 PM
Yeah… duh is right. No need for y (5)
GNBTQ Generex Biotechnology Corp.
06/22/2021 5:03:45 PM
Joe, the funny thing is that your p (4)
GNBTQ Generex Biotechnology Corp.
06/22/2021 12:48:34 AM
As I think I mentioned when the las (6)
GNBTQ Generex Biotechnology Corp.
06/19/2021 10:36:05 PM
Well, Rv, I suppose should clarify (2)
GNBTQ Generex Biotechnology Corp.
06/19/2021 2:34:51 PM
Oh, I didn't mean for my post to se (4)
GNBTQ Generex Biotechnology Corp.
06/19/2021 2:10:30 PM
Yes, the true build-outs in AZ and (4)
GNBTQ Generex Biotechnology Corp.
06/19/2021 1:10:53 PM
Which is why, until I'm told otherw (2)
GNBTQ Generex Biotechnology Corp.
06/18/2021 10:08:24 AM
Yeah, I saw that. It was an odd sta (2)
GNBTQ Generex Biotechnology Corp.
06/15/2021 2:37:26 PM
I’m going to say: 1). NGIO listin (5)
GNBTQ Generex Biotechnology Corp.
06/14/2021 7:53:26 PM
Well, as far as missed deadlines go (6)
GNBTQ Generex Biotechnology Corp.
06/14/2021 5:15:36 PM
I assume everybody saw the NT 10-Q (1)
GNBTQ Generex Biotechnology Corp.
06/07/2021 10:11:26 AM
Interesting to see KRBP up another (5)
GNBTQ Generex Biotechnology Corp.
06/07/2021 1:21:09 AM
Also, the 8K for the current China (4)
GNBTQ Generex Biotechnology Corp.
06/07/2021 1:07:49 AM
You started this by responding to a (5)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:48:50 AM
So you can come on and call me name (5)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:38:33 AM
I'm showing you facts that show som (5)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:27:41 AM
"Generex has agreed that if the Vac (1)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:23:38 AM
Ok, so please show me where the Chi (1)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:19:00 AM
Wow. Given the chance to provide cl (5)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:16:03 AM
Ah, I should take your word over an (1)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:14:33 AM
Have a set, Joe. Show me I'm wrong (3)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:12:40 AM
Thanks, OJ. I'm not hurt one bit, I (2)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:09:48 AM
Don't call names, show me some fact (2)
GNBTQ Generex Biotechnology Corp.
06/07/2021 12:03:50 AM
Are you speaking to the Excellagen
GNBTQ Generex Biotechnology Corp.
06/06/2021 11:58:52 PM
Oh, and the word is "than". Differe (5)
GNBTQ Generex Biotechnology Corp.
06/06/2021 11:54:22 PM
Nope... "baboon" it is. Nice work, (1)
GNBTQ Generex Biotechnology Corp.
06/06/2021 11:52:22 PM
Hey, Joe, I've read all the GNBT/NG (6)
GNBTQ Generex Biotechnology Corp.
06/06/2021 11:41:12 PM
Still here, Joe? Here's a Q for you (4)
GNBTQ Generex Biotechnology Corp.
06/06/2021 11:25:54 PM
Hey, Joe, I own 100s of thousands o (5)
GNBTQ Generex Biotechnology Corp.
06/06/2021 10:36:03 PM
Get your facts straight before you (6)
GNBTQ Generex Biotechnology Corp.
06/06/2021 10:17:47 PM
Doc, I would like to think we’ve (1)
GNBTQ Generex Biotechnology Corp.
06/04/2021 10:03:37 AM
Doc, thanks so much for all you do (10)
GNBTQ Generex Biotechnology Corp.
06/03/2021 12:55:38 PM
I don't think they "paid someone" i (5)
GNBTQ Generex Biotechnology Corp.
05/28/2021 7:57:32 PM
Fully agreed, Cody. I personally ha (8)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Sound Group Finalizes Share Repurchase Program Successfully
  • Sagimet Biosciences Set to Showcase Fibrosis Findings at AASLD
  • Shoals Technologies Group, Inc. Upcoming Earnings Release
  • Ocular Therapeutix Innovation Highlighted at Scientific Conferences
  • Axsome Therapeutics Financial Update: Conference Call on Q3 2025
  • Insight into USA Rare Earth's Upcoming Financial Conference Call
  • Sono-Tek Corporation to Host Earnings Call on Financial Results
  • Akero Therapeutics Unveils Promising Efruxifermin Data for Liver Disease
  • Akero Therapeutics Showcases Efruxifermin Data at AASLD 2025
  • Aduro Clean Technologies Announces Conference Participation in 2025
  • Fractyl Health's Innovative Gene Therapy Shows Weight Loss Promise
  • Aduro Clean Technologies Debuts at Investment Conference
  • Anfield Energy's Velvet-Wood Mine Project Gains Momentum
  • Ocular Therapeutix Highlights Upcoming Scientific Engagements
  • Rekor Systems Partners with Georgia DOT for Major Contract
  • Caliber Properties Advances EV Charging Infrastructure Growth
  • Balchem Corporation to Host Q3 2025 Financial Results Call
  • Shoals Technologies Group Set for Q3 2025 Earnings Call
  • Sono-Tek Prepares for Earnings Call: Insights and Innovations
  • Sagimet Biosciences to Present Key Findings at AASLD 2025
  • GXO Strengthens Global Logistics Partnership with Dolce&Gabbana
  • Balchem Corporation Prepares for Q3 2025 Financial Review
  • Axsome Therapeutics Set to Share Q3 2025 Financial Insights
  • Zeta Network Group Partners with SOLV Foundation for Innovation
  • EnviroGold Secures Initial Funding to Propel Growth Strategy
  • Exploring Sustainable Farming with WSSA and NAICC's Insights
  • Exciting Q3 2025 Conference Call Details from Eldorado Gold
  • Jade Biosciences Secures $135 Million in Innovative Funding
  • Evergold Corp. Proposes Strategic Share Consolidation Plan
  • Kyndryl Unveils AI-Driven Aviation Cloud Solution for Airlines
  • NeoVolta Secures Strategic Acquisition Aiming for Growth Boost
  • Eldorado Gold Sets Exciting Q3 2025 Conference Call Event
  • NeoVolta's Strategic Move with Neubau Energy Enhances Battery Systems
  • Cognia's Innovative Accreditation Enhancements for Schools
  • Exploring the Future of Autoimmune Disease Treatment with JADE201
  • Market Experts Highlight Inflation Concerns and Dollar Risks
  • Children's Medical Center Dallas Achieves Top Pediatric Rankings
  • Tech Leaders Warn Against AI Overvaluation and Market Risks
  • Novavax Marks Major Progress with Sanofi, Tapping Milestone Funds
  • Trump's Infrastructure Initiative Sparks Mining Opportunity in Alaska
  • Elevate LLC Strengthens Market Position with Investment
  • Investing in Industrial Stocks: A Smart October Move
  • Peer AI Secures $12.1M to Revolutionize Drug Approval Processes
  • Cyngn's CEO Discusses Strategic Initiatives for Business Growth
  • McCormick & Company Delivers Strong Growth Amid Challenges
  • OppFi's Upcoming Q3 2025 Earnings Report and Insights
  • Alzheimer's Disease Diagnosis: A Call for Immediate Action
  • TORL BioTherapeutics Clinches $96M Financing for Cancer Therapy
  • Empowering Entrepreneurs: Prospera’s Success Stories Event
  • Ovii Unveils Tropical Flavor for Women's Health Support
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site